We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – News and Features

News

Isarna Therapeutics Raises Euro 13 Million from New and Current Investors

Euro 13 million raised in equity from AT NewTec and MIG-managed funds.
News

Stellar Issues Year-End Results and Highlights from 2013

Company announces financial results and operational highlights for 2013.
News

Stem Cell Therapeutics Completes $33 Million Private Placement

Financing proceeds used to advance the Company’s CD47 cancer stem cell program.
News

Stellar Announces Collaboration with Amaran Biotechnology, Inc.

Collaboration agreement to develop and evaluate methods for the manufacture of OBI-822 active immunotherapy.
News

Adaptimmune Announces Interim Results from a Phase I/II Trial of Engineered T Cells

Study continues to report encouraging response rates, safety and proof of mechanism.
News

Droplet Digital PCR Enables Measurement of Potential Cancer Survival Biomarker

Study paves the way for further research into the role of TIL quantification in immunotherapy and as a cancer survival predictor.
News

Interim Results from Phase I/II Trial of Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma

Adaptimmune announces that study continues to report encouraging response rates, safety and proof of mechanism.
News

Agalimmune Founded to Develop Immunotherapeutics for Cancer

Funding will be used to continue the translation of Alphaject™ licensed from UMMS.
News

Study Finds Gut Microorganisms May Determine Cancer Treatment Outcome

An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy.
News

StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer

Mr. Schiffman will join Company’s executive team, effective January 1, 2014.
Advertisement